Signati Medical
RI - ProvidenceBiotechnology
Focus: Signati Medical is a 2024-founded biotechnology company headquartered in Providence, RI, focused on developing the Signati Separo™ Vessel Sealing System for non-invasive vasectomy procedures. The company is at an early stage with minimal public disclosure of scale or financials.
Profile data last refreshed 2h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Signati Medical
AI assessmentNot HiringNo open roles listed right now. Follow Signati Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
The Signati Separo™ Vessel Sealing System
VasectomyClinical Trials (1)
NCT06402773A Safety Study in Human Subjects Evaluating the Use of the Signati System for Vasectomy
N/AHelp build intelligence for Signati Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.